Researchers are saying that, from an infection control perspective, C. auris acts more like a multidrug-resistant, healthcare-associated bacteria than like a typical yeast, according to an article on the MedPage website.
"It is a new bug using old tricks mastered by some well-known, multidrug resistant organisms," they said.
Identifying, treating, and preventing Candida auris is a challenge facing more and more healthcare settings.
Findings presented at the 2019 ASM Microbe meeting in San Francisco by researchers from the Centers for Disease Control and Prevention found that patients with C. auris appear to "shed" the pathogen from their skin into their environment, which could potentially play a factor in transmission.
5 Reasons Engineering is the Edge in Healthcare Master Planning
Building an AI-Ready Healthcare Facility 
Family Medical Associates of Raleigh Reports April 2026 Data Breach
Every Detail Matters: A Patient's Story of Healing, Hope and Healthcare Facilities
Geisinger Wyoming Valley Medical Center Tops Off New 11-Story Tower